Denville, NJ, United States of America

Patrick Niven

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Patrick Niven

Introduction

Patrick Niven is an accomplished inventor based in Denville, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of Hepatitis C. His innovative work has the potential to improve early detection methods, which is crucial for effective treatment and management of the disease.

Latest Patents

Patrick Niven holds a patent for a groundbreaking invention titled "Hepatitis C antigen–antibody combination assay for the early detection of infection." This patent describes an ELISA-based assay designed to detect HCV infection earlier than currently used methods. By utilizing a combination of HCV antigens and anti-core antibodies, this assay captures HCV more effectively, enhancing the screening process for blood donations.

Career Highlights

Throughout his career, Patrick has focused on developing diagnostic tools that can lead to better health outcomes. His dedication to innovation in the medical field has positioned him as a notable figure among inventors in this area.

Collaborations

Patrick has worked alongside talented colleagues, including Chander Bahl and Antonio Samson. Their collaborative efforts have contributed to the advancement of diagnostic technologies and have fostered a productive research environment.

Conclusion

Patrick Niven's contributions to the field of medical diagnostics, particularly through his patent for an early detection assay for Hepatitis C, highlight his innovative spirit and commitment to improving healthcare. His work exemplifies the impact that dedicated inventors can have on society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…